Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.19.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid- in Capital [Member]
Accumulated Deficit [Member]
Total
Beginning balance at Dec. 31, 2016 $ 24 $ 239,725 $ (137,430) $ 102,319
Beginning balance, shares at Dec. 31, 2016 23,801,000      
Exercise of common stock options 80 80
Exercise of common stock options, shares 57,000      
Stock-based compensation 614 614
Sale of common stock, net of transaction costs 3,000 3,000
Sale of common stock, net of transaction costs shares 417,000      
Net loss (613) (613)
Ending Balance at Dec. 31, 2017 $ 24 243,419 (138,043) 105,400
Ending Balance, shares at Dec. 31, 2017 24,275,000      
Exercise of common stock options 228 228
Exercise of common stock options, shares 143,000      
Stock-based compensation 562 562
Sale of common stock, net of transaction costs $ 5 7,679 7,684
Sale of common stock, net of transaction costs shares 4,435,000      
Net loss (49,048) (49,048)
Conversion of debt instruments $ 1 2,061 2,062
Conversion of debt instruments, shares 1,085,000      
Ending Balance at Dec. 31, 2018 $ 30 $ 253,949 $ (187,091) $ 66,888
Ending Balance, shares at Dec. 31, 2018 29,938,000